Trial intelligence / Profile preview

Mild Hypothermia After Endovascular Treatment in Acute Ischemic Stroke

NCT02985060Phase 2Unknown

Sponsor
Seoul National University Hospital
Start
Nov 2016
Primary completion
Nov 2017
Countries
1
01

Overview

Phase 2, randomised, open-label trial in ischemic stroke (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Favorable outcome at 3 months and Mortality at 3 months. Status: unknown.

02

Conditions

ischemic stroke

Beyond the preview

Go deeper on NCT02985060.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02985060.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call